Absorption and Clearance of Ceftazidime during CAPD

Abstract

Get full access to this article

View all access options for this article.

References

Keane

W.F.

, Everett

E.D.

, Golper

T.A.

Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update.

Perit Dial Int 1993; 13: 14–28.

Milliken

S.P.

, Matze

G.R.

, Keane

W.F.

Anti-microbial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.

Perit Dial Int 1991; 11: 252–60.

Report of a Working Party of the British Society for Anti-microbial Chemotherapy.

Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis.

Lancet 1987; 1: 845–8.

Beaman

, Solaro

, McGonigle

R.J.S.

, Michael

, Adu

Vancomycin and ceftazidime in the treatment of CAPD peritonitis.

Nephron 1989; 51: 51–5.

Gray

H.H.

, Goulding

, Eykyn

S.J.

Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.

Clin Nephrol 1985; 23: 81–4.

Bunke

C.M.

, Aronoff

G.A.

, Brier

M.E.

, Sloan

R.S.

, Luft

F.C.

Vancomycin kinetics during continuous ambulatory peritoneal dialysis.

Clin Pharmacol Ther 1983; 34: 631–7.

Pancorbo

, Comty

Peritoneal transport of vancomycin in four patients undergoing continuous ambulatory peritoneal dialysis.

Nephron 1982; 31: 37–9.

Bastani

, Spyker

D.A.

, Westervely

F.B.

Peritoneal absorption of vancomycin during and after resolution of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients.

Perit Dial Int 1988; 8: 135–6.

Bastani

, Freer

, Read

Treatment of gram positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.

Nephron 1987; 45: 283–5.